Keyphrases
Monoclonal Antibody
100%
Proliferating Cell nuclear Antigen
100%
Syndrome Diagnosis
100%
Cell Surface
100%
Cutaneous T-cell Lymphoma
100%
Targeted Immunotherapy
100%
Sézary Syndrome
100%
Lymphoma Cells
80%
Peripheral Blood Mononuclear Cells
60%
Cancer Cells
40%
Natural Killer Cells
40%
Healthy Donors
40%
NKp44
40%
Malignant Cells
20%
Most Common Form
20%
Cell Toxicity
20%
NK Cell Activity
20%
Natural Killer
20%
Life Cycle Analysis
20%
Cytotoxic Activity
20%
Immunostaining
20%
Peripheral Blood
20%
Immune Checkpoint
20%
Atypical Phenotype
20%
Mycosis Fungoides
20%
Potential Biomarkers
20%
Natural Killer Cell Cytotoxicity
20%
Imaging Flow Cytometry
20%
M Phase
20%
Primary Cutaneous T-cell Lymphoma
20%
Flow Cytometric Sorting
20%
Cytotoxic Assay
20%
Sorted Cells
20%
Peripheral Blood NK Cells
20%
Killer Inhibitory Receptor
20%
Checkpoint Ligands
20%
Peripheral Blood Natural Killer Cells
20%
Medicine and Dentistry
Natural Killer Cell
100%
Monoclonal Antibody
100%
Proliferating Cell Nuclear Antigen
100%
Immunotherapy
100%
Cell Surface
100%
Sezary Syndrome
100%
Peripheral Blood Mononuclear Cell
75%
Cutaneous T Cell Lymphoma
75%
Cutaneous T-Cell Lymphoma Cell Line
75%
Cancer Cell
50%
Flow Cytometry
50%
Cytotoxicity
50%
Biological Marker
25%
Secretion (Process)
25%
Immunohistochemistry
25%
Enzyme Linked Immunosorbent Assay
25%
Mycosis fungoides
25%
Lymphoma Cell
25%
Cell Cycle M Phase
25%
Natural Cytotoxicity Triggering Receptor 2
25%
Cell-Cycle Analysis
25%
Immunology and Microbiology
Monoclonal Antibody
100%
Natural Killer Cell
100%
Cell Surface
100%
Cycline
100%
Immunotherapy
100%
T Cell
75%
Peripheral Blood Mononuclear Cell
75%
Cutaneous T-Cell Lymphoma Cell Line
75%
Cancer Cell
50%
Cytotoxicity
50%
Secretion (Process)
25%
Coculture
25%
ELISA
25%
Cell Cycle
25%
Natural Cytotoxicity Triggering Receptor 2
25%
Lymphoma Cell
25%
Flow Imaging
25%
Cell Cycle M Phase
25%
Immunostaining
25%
Cell Selection
25%